NetworkNewsBreaks – Earth Science Tech, Inc. (ET
Post# of 333
(Total Views: 316)
Posted On: 12/18/2018 6:13:24 PM
NetworkNewsBreaks – Earth Science Tech, Inc. (ETST) Orders First Commercial Production Run and Early 2019 Launch of Hygee
Innovative biotechnology company Earth Science Tech (OTCQB: ETST) this morning announced that it has ordered the first commercial production run of Hygee, its new medical device for women that enables discreet, anonymous testing for sexually transmitted infections (“STIs”). According to the update, the official launch is scheduled for early 2019, and initial marketing will target North America, South America, Asia and Africa. The company will package Hygee in English, French, Portuguese, Spanish, Vietnamese and Arabic to reach a wide consumer audience. “No other existing method of collecting genital specimens from women is more convenient or more efficient than Hygee,” ETST CEO and Chief Science Officer Dr. Michel Aube stated in the news release. “Through intentional design, Hygee is a ‘mistake proof’ medical device with extremely simple instructions that allow any woman, regardless of age or education the assurance of correctly using the kit on the first try. With roughly 130 million new chlamydia cases diagnosed yearly, according to the WHO, Hygee is dedicated to this area of women’s health.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Innovative biotechnology company Earth Science Tech (OTCQB: ETST) this morning announced that it has ordered the first commercial production run of Hygee, its new medical device for women that enables discreet, anonymous testing for sexually transmitted infections (“STIs”). According to the update, the official launch is scheduled for early 2019, and initial marketing will target North America, South America, Asia and Africa. The company will package Hygee in English, French, Portuguese, Spanish, Vietnamese and Arabic to reach a wide consumer audience. “No other existing method of collecting genital specimens from women is more convenient or more efficient than Hygee,” ETST CEO and Chief Science Officer Dr. Michel Aube stated in the news release. “Through intentional design, Hygee is a ‘mistake proof’ medical device with extremely simple instructions that allow any woman, regardless of age or education the assurance of correctly using the kit on the first try. With roughly 130 million new chlamydia cases diagnosed yearly, according to the WHO, Hygee is dedicated to this area of women’s health.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)